Sponsor of the Day:
Jerkmate
https://springworkstx.com/pipeline/mirdametinib/
Mirdametinib - NF1 Treatment - SpringWorks Therapeutics
Feb 28, 2025 - Mirdametinib is an oral small molecule designed to inhibit MEK1 and MEK2, which are proteins that occupy pivotal positions in the MAPK pathway.
springworks therapeuticsmirdametinibnf1treatment
https://www.springworks.in/the-shape-of-work/
The Shape of Work - HR Slack Community by Springworks
work hrslack communityshapespringworks
https://springworkstx.com/
SpringWorks Therapeutics - Unlocking Targeted Oncology
Oct 22, 2025 - We relentlessly pursue every possibility to create new cancer breakthroughs and power our approach with people who think hard, care hard, and act with urgency....
springworks therapeuticsunlockingtargetedoncology
https://www.greatplacetowork.com/certified-company/7039053
Working at SpringWorks Therapeutics | Great Place To Work®
Is SpringWorks Therapeutics a great place to work for?
springworks therapeuticsgreat placeworking
https://www.springworks.in/blog/
Springworks Blog - Everything about the Future of Hiring and Recruiting
We want to help you learn about the human resources and employee engagement. Get practical advice on remote work, team building, and succeeding at work.
blog everythingspringworksfuturehiringrecruiting
https://springworkstx.com/patients/neurofibromatosis-type-1/
NF1 Plexiform Neurofibroma Trial - SpringWorks Therapeutics
May 12, 2025 - When there are no approved treatments for a condition, we must develop them. Clinical trials are studies that collect data to determine if a new drug is safe...
springworks therapeuticsnf1trial